Papers
5
Total Citations
136
H-Index
4
About
Dr. Chongwu Li is a pioneering thoracic surgeon whose research focuses on advancing minimally invasive surgical techniques for lung cancer, particularly for complex and advanced-stage disease. His major contributions center on establishing the safety, efficacy, and oncological equivalence of robotic-assisted thoracoscopic surgery (RATS) compared to traditional open thoracotomy and video-assisted thoracoscopic surgery (VATS). Dr. Li’s landmark work includes a multicenter, randomized controlled trial demonstrating that RATS reduces perioperative complications while achieving similar long-term survival in patients with clinical N2 stage non-small cell lung cancer (NSCLC), a population traditionally considered high-risk for minimally invasive approaches. His highly cited 2019 study comparing robotic-assisted lobectomy with VATS for stage IIB–IIIA NSCLC has garnered 74 citations, underscoring its influence. Additionally, Dr. Li has contributed to the technical literature on complex procedures, such as three-arm RATS for locally advanced N2 disease and robotic-assisted sleeve resections. Through rigorous clinical trials and technical innovations, Dr. Li has helped expand the boundaries of minimally invasive thoracic surgery, offering patients with advanced lung cancer less invasive treatment options without compromising oncologic outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5Robotic-assisted thoracoscopic right upper lobe sleeve resection3 citations · 2019